[go: up one dir, main page]

AU6764798A - Leukotriene antagonists useful for treating cystic fibrosis - Google Patents

Leukotriene antagonists useful for treating cystic fibrosis

Info

Publication number
AU6764798A
AU6764798A AU67647/98A AU6764798A AU6764798A AU 6764798 A AU6764798 A AU 6764798A AU 67647/98 A AU67647/98 A AU 67647/98A AU 6764798 A AU6764798 A AU 6764798A AU 6764798 A AU6764798 A AU 6764798A
Authority
AU
Australia
Prior art keywords
cystic fibrosis
leukotriene antagonists
treating cystic
antagonists useful
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67647/98A
Inventor
Jerome H. Fleisch
William T Jackson
Jason S. Sawyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU6764798A publication Critical patent/AU6764798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU67647/98A 1997-03-21 1998-03-19 Leukotriene antagonists useful for treating cystic fibrosis Abandoned AU6764798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4087097P 1997-03-21 1997-03-21
US60040870 1997-03-21
PCT/US1998/005455 WO1998042650A2 (en) 1997-03-21 1998-03-19 Leukotriene antagonists useful for treating cystic fibrosis

Publications (1)

Publication Number Publication Date
AU6764798A true AU6764798A (en) 1998-10-20

Family

ID=21913422

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67647/98A Abandoned AU6764798A (en) 1997-03-21 1998-03-19 Leukotriene antagonists useful for treating cystic fibrosis

Country Status (2)

Country Link
AU (1) AU6764798A (en)
WO (1) WO1998042650A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1127882A1 (en) 2000-01-25 2001-08-29 Pfizer Products Inc. Tetrazole compounds as thyroid receptor ligands
JP2001247459A (en) 2000-03-03 2001-09-11 Oakland Uniservices Ltd Cancer combination therapy
JP2004505047A (en) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド Cancer treatment by combined therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
JP5207972B2 (en) 2006-10-12 2013-06-12 株式会社医薬分子設計研究所 Carboxylic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
US5324743A (en) * 1992-12-10 1994-06-28 Eli Lilly And Company Leukotriene B4 antagonists
US5478857A (en) * 1993-12-23 1995-12-26 Eli Lilly And Company Use of PLA2 inhibitors as treatment for alzheimer's disease
US5543428A (en) * 1994-08-31 1996-08-06 Eli Lilly And Company Method for treating resistant tumors

Also Published As

Publication number Publication date
WO1998042650A2 (en) 1998-10-01
WO1998042650A3 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
AU5273398A (en) Atomizer
AU1093999A (en) Flavonoids for cystic fibrosis therapy
AU2420797A (en) Novel cystic fibrosis treatment
GB9702944D0 (en) Reducing fibrosis
AU6514898A (en) Detergent particle
AU6450298A (en) Leukotriene antagonists useful for treating squamous cell carcinoma
AU4488397A (en) Detergent particle
AU9664198A (en) Method for the treatment of cystic fibrosis
AU6764798A (en) Leukotriene antagonists useful for treating cystic fibrosis
AU9548698A (en) Incinerator apparatus
AU6569898A (en) Leukotriene antagonists useful for treating iritis
AU6185698A (en) Methods and compositions for treating cystic fibrosis
AUPP989499A0 (en) Treated closures 3
AU2652395A (en) Leukotriene b4 antagonists
AU6572198A (en) Leukotriene antagonists useful for treating dermatoses
AU6570798A (en) Leukotriene antagonists useful for treating gingivitis
AU6450498A (en) Leukotriene antagonists useful for treating gout
AU2042097A (en) Treatment for pulmonary fibrosis
AU6743498A (en) Rotatable handgrip controller
AU5384298A (en) Oscillating hauloff
AUPO947597A0 (en) Improved foldable box
AUPP989299A0 (en) Treated closures 1
AUPP989399A0 (en) Treated closures 2
AU8860498A (en) Cleaning method
AU2537200A (en) Atomizer